Zoetis Inc.
73.31USD
-0.2500 (-0.34%)
Computing valuation metrics…
Valuation
P/E (TTM)
11.58x
P/E (Forward)
11.22x
EV/EBITDA
9.31x
EV/Revenue
3.98x
P/S (TTM)
3.18x
P/B
9.62x
FCF Yield
7.65%
Dividend Yield
2.88%
Gross Margin
71.54%
Operating Margin
40.72%
Net Margin
27.49%
Peer Comparison — Drug Manufacturers - Specialty & Generic
| Company | Mkt Cap | P/E | EV/EBITDA | FCF Yield | Rev Growth | Div Yield |
|---|---|---|---|---|---|---|
| ZTSZoetis Inc. | $30.29B | 11.58x | 9.31x | 7.65% | -0.24% | 2.88% |
| TEVATeva Pharmaceutical Industries Limited | $42.84B | 61.27x | 13.14x | 5.18% | -0.80% | — |
Subject metrics from SEC filings where available; peer metrics from cached market data.
| $18.95B |
| — |
| 7.27x |
| 14.13% |
| 4.90% |
| 2.89% |
| HIMSHims & Hers Health, Inc. | $6.51B | — | — | 13.05% | 38.20% | — |
| LQDALiquidia Corporation | $6.19B | 49.37x | 35.09x | 1.20% | 1842.70% | — |
| KNSAKiniksa Pharmaceuticals International, plc | $6.13B | 79.31x | 53.88x | 2.06% | 55.40% | — |
| AMLXAmylyx Pharmaceuticals, Inc. | $3.61B | — | — | -2.14% | — | — |
| BHCBausch Health Companies Inc. | $2.30B | — | 5.71x | 62.23% | 12.70% | — |
| ADCTADC Therapeutics SA | $165.97M | — | — | -41.04% | 2.20% | — |